4 results
To confirm the pre-clinically demonstrated technical accuracy and safety of the newly developed MR Linac in the clinical setting.
The primary objective of the study is to evaluate the reduction of low density lipoprotein cholesterol (LDL-C) by evinacumab in comparison to placebo after 16 weeks in patients with primary hypercholesterolemia (heterozygous familial…
The purpose of this study is to determine the effect of treatment on cognition, overall clinical status and underlying pathology in subjects with a risk of occurrence of the first clinical symptoms of Alzheimer's disease.People without…
The main objective of the study is to test if burst SCS is clinically non-inferior to conventional SCS in patients already successfully treated with conventional SCS. The secondary objective of the study is to evaluate patient satisfaction and…